Alnugranogene Aldeparvovec
C9orf72
Passage Bio, Inc.gene_therapyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 33/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the C9orf72 cohort.
| Asset / Sponsor | Phase | Rating |
|---|
Same molecule, other indications
Alnugranogene Aldeparvovec is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →